|
Warburg did not disclose the size of the investment. Since it
was founded in 2001, Hygiena has become one of the larger
providers of rapid testing technologies in the United States.
The company manufactures testing and sanitation products that it
sells to industrial food processors, healthcare facilities, life
science researchers and others in more than fifty countries.
Hygenia will join Warburg's portfolio of healthcare-oriented
investments, which includes Accriva Diagnostics, China Biologic
Products and Silk Road Medical.
Earlier this year, Warburg acquired a majority stake in DocuTAP,
which provides healthcare technology for urgent care.
Houlihan Lokey served as financial adviser to Hygiena.
(Reporting by Carl O'Donnell in New York; Editing by Jeffrey
Hodgson)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
|
